NCT06932081View on ClinicalTrials.gov

Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry

RecruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Adult Congenital Heart DiseaseCongenital Heart DiseaseSystemic Right VentricleTransposition of the Great ArteriesCongenitally Corrected Transposition of the Great ArteriesFontanSingle VentricleTetralogy of Fallot (TOF)
Interventions
DRUG

SGLT2 inhibitors

Treatment with any type and dose of sodium-glucose cotransporter 2 inhibitor.

Trial Locations (10)

10029

RECRUITING

Mount Sinai Fuster Heart Hospital, New York

21205

RECRUITING

Johns Hopkins University, Baltimore

49503

NOT_YET_RECRUITING

Helen DeVos Children's Hospital, Grand Rapids

2333ZA

RECRUITING

Leiden University Medical Center (LUMC), Leiden

Unknown

RECRUITING

Amsterdam University Medical Center, Amsterdam

RECRUITING

University Medical Center Utrecht, Utrecht

RECRUITING

Zan Mitrev Clinic, Skopje

RECRUITING

University Hospital of Wales, Cardiff

RECRUITING

Golden Jubilee University National Hospital, Glasgow

RECRUITING

Barts Heart Centre, London

All Listed Sponsors
lead

Leiden University Medical Center

OTHER